Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sankar D Navaneethan

Showing results (121-130 of 281) with videos related to

Pageof 29
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2009
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysisSankar D Navaneethan, Hans Yehnert, Fady Moustarah, et al.
Journal of the American Heart Association|February 29, 2024
Kidney Function Trajectories and Right Heart Failure Following LVAD ImplantationCarl P Walther, Andrew B Civitello, Harveen K Lamba, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 14, 2019
Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on HemodialysisChandan Vangala, Jingbo Niu, Maria E Montez-Rath, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2018
Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on HemodialysisChandan Vangala, Jingbo Niu, Colin R Lenihan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2008
Rituximab treatment of fibrillary glomerulonephritisMichael Collins, Sankar D Navaneethan, Miriam Chung, et al.
American Journal of Nephrology|October 18, 2014
Outcomes of infected cardiovascular implantable devices in dialysis patientsOluwaseun Opelami, Ankit Sakhuja, Xiaobo Liu, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 6, 2012
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-upHelen M Heneghan, Derrick Cetin, Sankar D Navaneethan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2025
Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetesAbiodun Idowu, Kevin Bryan Lo, Olayinka Adebolu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2009
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trialsSankar D Navaneethan, Suetonia C Palmer, Jonathan C Craig, et al.
European Radiology|March 26, 2021
Long-term inter-platform reproducibility, bias, and linearity of commercial PDFF MRI methods for fat quantification: a multi-center, multi-vendor phantom studyErika Schneider, Erick M Remer, Nancy A Obuchowski, et al.
Pageof 29

Showing results (121-130 of 281) with videos related to

Sort By:
Pageof 29
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2009
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysisSankar D Navaneethan, Hans Yehnert, Fady Moustarah, et al.
Journal of the American Heart Association|February 29, 2024
Kidney Function Trajectories and Right Heart Failure Following LVAD ImplantationCarl P Walther, Andrew B Civitello, Harveen K Lamba, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 14, 2019
Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on HemodialysisChandan Vangala, Jingbo Niu, Maria E Montez-Rath, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2018
Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on HemodialysisChandan Vangala, Jingbo Niu, Colin R Lenihan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2008
Rituximab treatment of fibrillary glomerulonephritisMichael Collins, Sankar D Navaneethan, Miriam Chung, et al.
American Journal of Nephrology|October 18, 2014
Outcomes of infected cardiovascular implantable devices in dialysis patientsOluwaseun Opelami, Ankit Sakhuja, Xiaobo Liu, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 6, 2012
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-upHelen M Heneghan, Derrick Cetin, Sankar D Navaneethan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2025
Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetesAbiodun Idowu, Kevin Bryan Lo, Olayinka Adebolu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2009
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trialsSankar D Navaneethan, Suetonia C Palmer, Jonathan C Craig, et al.
European Radiology|March 26, 2021
Long-term inter-platform reproducibility, bias, and linearity of commercial PDFF MRI methods for fat quantification: a multi-center, multi-vendor phantom studyErika Schneider, Erick M Remer, Nancy A Obuchowski, et al.
Pageof 29